Theriva Biologics special meeting fails due to lack of quorum; new meeting to be called

Theriva Biologics, Inc.

Special Meeting of Stockholders convened Dec. 15, 2025 lacked sufficient shares for quorum.
Company will call a new special meeting to seek stockholder approval for warrant exercise proposal.
Under Oct. 16, 2025 Inducement Agreement, company must hold meetings every 60 days until approval or warrants lapse.
Approval sought for issuance of up to 16,184,560 shares of common stock upon exercise of New Warrants.
Company will file and mail proxy materials for the new meeting, date and time to be announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.